Company intelligence / Profile preview

Aurolife Pharma

Dayton, New Jersey, United Statesaurolifepharma.com ↗

Ownership: Private
Development stage: Other

Overview

Aurolife has received US FDA approval for multiple ANDAs and manufactures a wide array of generic pharmaceuticals. The company operates cGMP-compliant facilities with DEA authorization for controlled substances. Recent FDA inspections have resulted in procedural observations but no material impact on operations.

Therapeutic areas: NeurologyDermatologyOncologyOtherCardiovascular
Modalities: Small moleculeOral solid dosage formsInhalersDermatological products
Industry: Biotech

Partnerships

Not explicitly stated; main relationship is vertical integration within the Aurobindo group.

Beyond the preview

Go deeper on Aurolife Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aurolife Pharma.

Explore the full profile